Replies to post #122252 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

We shouldn't have to have all 17 ART products on the market because once one is approved the rest will get approved because it's modular tech so the valuation should be $2.10 or higher just on the market looking forward.

So if a buyout happens with just ELI-200 on the market we would get bought out based on the value of the other 16 coming and their current market size/potential.